You have 9 free searches left this month | for more free features.

DEFB1 protein, human

Showing 9951 - 9975 of >10,000

STUDY
CONDITIONS
INTERVENTIONS
LOCATIONS

Multiple Myeloma Trial in Zhengzhou, Shanghai, Wenzhou (Human BCMA targeted T Cells Injection)

Recruiting
  • Multiple Myeloma
  • Human BCMA targeted T Cells Injection
  • Zhengzhou, Henan, China
  • +2 more
Feb 25, 2021

Cell- and Tissue-Based Therapy, Cartilage Injury, Knee Injuries Trial (Synovial Tissue and Fat Pad Stromal Vascular Fraction)

Not yet recruiting
  • Cell- and Tissue-Based Therapy
  • +2 more
  • Synovial Tissue and Fat Pad Stromal Vascular Fraction
  • (no location specified)
Nov 3, 2021

Soluble Factors and Renal Outcome in Preeclampsia

Completed
  • Preeclampsia
  • Renal Function
  • Renal function
  • proteinuria
  • Bangkok, Thailand
    Faculty of Medicine,Vajira Hospital
Jun 24, 2021

Combination Acthar Gel and Tacrolimus in Treatment of Steroid

Suspended
  • Nephrotic Syndrome
  • Acthar Gel and Tacrolimus
  • Chattanooga, Tennessee
    Nephronet
Feb 15, 2021

HPV Vaccination on Cervical High Grade Lesions in France

Completed
  • Human Papillomavirus Infection
  • biological sample analysis
  • Besançon, France
    CHU Besançon
Aug 20, 2021

Malignant Melanoma, Medullary Thyroid Cancer, Glioblastoma Trial in United States (Rovalpituzumab tesirine, Dexamethasone)

Terminated
  • Malignant Melanoma
  • +7 more
  • Gilbert, Arizona
  • +29 more
Sep 21, 2020

Diabetes, Type 2 Trial in Odense (Metformin, Caffeine, Efavirenz)

Terminated
  • Diabetes Mellitus, Type 2
  • Odense, Region Of Southern Denmark, Denmark
    University of Southern Denmark
Jun 14, 2022

Behavior Trial in Eugene (Visual stimulus similarity, fMRI, Eye tracking)

Not yet recruiting
  • Behavior
  • Visual stimulus similarity
  • +2 more
  • Eugene, Oregon
    University of Oregon
Oct 11, 2021

Post-polio Syndrome Trial in Worldwide (Flebogamma 5% DIF, Placebo)

Suspended
  • Post-polio Syndrome
  • Flebogamma 5% DIF
  • Placebo
  • Saint Louis, Missouri
  • +26 more
Jan 27, 2022

Chronic Granulomatous Disease Trial run by the NIAID (Sirolimus, Cyclophosphamide, Alemtuzumab)

Recruiting
  • Chronic Granulomatous Disease
  • Bethesda, Maryland
    National Institutes of Health Clinical Center
Jul 23, 2022

Sickle Cell Disease, Sickle Cell Anemia Trial run by the NHLBI (Biotin label)

Recruiting
  • Sickle Cell Disease
  • Sickle Cell Anemia
  • Biotin label
  • Bethesda, Maryland
    National Institutes of Health Clinical Center
Aug 11, 2022

Generate Real World Data On Tofacitinib Induction Therapy and

Recruiting
  • Ulcerative Colitis
  • Stool sample collection
  • Bern, Bern (de), Switzerland
  • +8 more
Jan 25, 2023

Dry Eye Disease, Dry Eye, Kerato Conjunctivitis Sicca Trial in Catania (Cross-linked hyaluronic acid eye drops)

Recruiting
  • Dry Eye Disease
  • +3 more
  • Cross-linked hyaluronic acid eye drops
  • Catania, CT, Italy
    Azienda Ospedaliero-Universitaria Policlinico "G.Rodolico - San
Apr 11, 2023

Type 1 Diabetes, Hypoglycemia, Arrythmia Trial in Cambridge, Manchester (Hybrid closed-loop system (CamAPS FX), Sensor augmented

Completed
  • Type 1 Diabetes Mellitus
  • +2 more
  • Hybrid closed-loop system (CamAPS FX)
  • Sensor augmented pump therapy
  • Cambridge, United Kingdom
  • +1 more
Sep 4, 2021

Participants With or Without Stable Co-morbidities Associated With Progression to Severe COVID-19 Trial in Worldwide

Active, not recruiting
  • Participants With or Without Stable Co-morbidities Associated With Progression to Severe COVID-19
  • Ad26.COV2.S
  • Placebo
  • Vestavia Hills, Alabama
  • +125 more
Jan 17, 2023

Melanoma (Skin) Trial in Madison (hu14.18-IL2 fusion protein)

Completed
  • Melanoma (Skin)
  • hu14.18-IL2 fusion protein
  • Madison, Wisconsin
    University of Wisconsin Paul P. Carbone Comprehensive Cancer Cen
Nov 15, 2019

Haemophilus Influenzae Type B Infection Trial in United States (Vaxelis, PedvaxHIB)

Recruiting
  • Haemophilus Influenzae Type B Infection
  • Chinle, Arizona
  • +4 more
Mar 29, 2022

Gestational Diabetes, Pregnancy, High Risk, Overweight and Obesity Trial in Indianapolis (Intensive glycemic targets, Standard

Recruiting
  • Gestational Diabetes
  • +2 more
  • Intensive glycemic targets
  • Standard glycemic targets
  • Indianapolis, Indiana
    Indiana University
Mar 15, 2022

Hepatocellular Carcinoma by BCLC Stage Trial in Rennes (Tislelizumab)

Not yet recruiting
  • Hepatocellular Carcinoma by BCLC Stage
  • Rennes, France
    Centre Eugene Marquis
Jan 16, 2023

Early Breast Cancer Trial in Spain (Doxorubicin, Cyclophosphamide, Taxane)

Active, not recruiting
  • Early Breast Cancer
  • Santiago De Compostela, A Coruña, Spain
  • +27 more
Jul 11, 2022

Fatigue Trial in Tamshui (PG2, Placebo)

Completed
  • Fatigue
  • Tamshui, Taipei, Taiwan
    Mackay Memorial Hospital
Jun 13, 2022

Adenocarcinoma - GEJ, Cancer of Esophagus Trial in Cambridge (Temozolomide, Temozolomide 50mg/m2/day, Temozolomide 3 month)

Recruiting
  • Adenocarcinoma - GEJ
  • Cancer of Esophagus
  • Cambridge, Cambridgeshire, United Kingdom
    Cambridge University Hospitals NHS Foundation Trust
Oct 6, 2021

African Trypanosomiases, West African; Trypanosomiasis, Sleeping Sickness; West African Trial in Kinshasa, Bouaké, Conakry

Completed
  • African Trypanosomiases
  • +3 more
  • Rapid diagnostic test (RDT)
  • Serological and molecular tests on DBS
  • Kinshasa, Congo, The Democratic Republic of the
  • +2 more
Feb 18, 2021

Observational Study of the Use of DBLG1 System in Real Life

Active, not recruiting
  • Type1diabetes
  • DBLG1 System
  • Bobigny, France
  • +18 more
Mar 10, 2022

Kidney Stone Trial in Ankara (Genetic analysis)

Completed
  • Kidney Stone
  • Genetic analysis
  • Ankara, Turkey
    Omer Gokhan Doluoglu
Mar 17, 2021